Myeloperoxidase
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Myeloperoxidase
| ||||||||||||||
| ||||||||||||||
| Myeloperoxidase drawn from PDB 1D7W. | ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | MPO; | |||||||||||||
| External IDs | OMIM: 606989 MGI: 97137 Homologene: 55450 | |||||||||||||
| ||||||||||||||
| RNA expression pattern | ||||||||||||||
|
| ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 4353 | 17523 | ||||||||||||
| Ensembl | ENSG00000005381 | ENSMUSG00000009350 | ||||||||||||
| Uniprot | P05164 | Q571G0 | ||||||||||||
| Refseq | NM_000250 (mRNA) NP_000241 (protein) | NM_010824 (mRNA) NP_034954 (protein) | ||||||||||||
| Location | Chr 17: 53.7 - 53.71 Mb | Chr 11: 87.61 - 87.62 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
|
WikiDoc Resources for Myeloperoxidase | |
|
Articles | |
|---|---|
|
Most recent articles on Myeloperoxidase Most cited articles on Myeloperoxidase | |
|
Media | |
|
Powerpoint slides on Myeloperoxidase | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Myeloperoxidase at Clinical Trials.gov Trial results on Myeloperoxidase Clinical Trials on Myeloperoxidase at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Myeloperoxidase NICE Guidance on Myeloperoxidase
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Myeloperoxidase Discussion groups on Myeloperoxidase Patient Handouts on Myeloperoxidase Directions to Hospitals Treating Myeloperoxidase Risk calculators and risk factors for Myeloperoxidase
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Myeloperoxidase | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Myeloperoxidase (MPO) is a peroxidase enzyme (EC 1.11.1.7) most abundantly present in neutrophil granulocytes (a subtype of white blood cells). It is a lysosomal protein stored in azurophilic granules of the neutrophil. MPO has a heme pigment, which causes its green color in secretions rich in neutrophils, such as pus and some forms of mucus.
Studies have demonstrated neutrophil activation as they pass through the coronary bed in patients with ACS.[1] Furthermore, MPO levels have recently been shown to be an independent predictor of outcome in ACS.[1] [1]
Structure
The 150 kDa MPO protein is a dimer consisting of two 15 kDa light chains and two variable-weight glycosylated heavy chains bound to a prosthetic heme group. Three isoforms have been identified, differing only in the size of the heavy chains[1]. It contains a calcium binding site with 7 ligands forming a pentagonal pyramid conformation. One of the ligands is the carbonyl group of Asp 96. Calcium binding is important for structure of the active site because of Asp 96's close proximity to the catalytic His95 side chain.
Function
MPO produces hypochlorous acid (HOCl) from hydrogen peroxide (H2O2) and chloride anion (Cl-) during the neutrophil's respiratory burst. It requires heme as a cofactor. Furthermore, it oxidizes tyrosine to tyrosyl radical using hydrogen peroxide as oxidizing agent.[1]
Hypochlorous acid and tyrosyl radical are cytotoxic, so they are used by the neutrophil to kill bacteria and other pathogens.
Genetics
The gene is located on chromosome 17 (17q23.1).
Role in disease
Myeloperoxidase deficiency is a hereditary deficiency of the enzyme, which predisposes to immune deficiency.[1]
Antibodies against MPO have been implicated in various types of vasculitis, most prominently crescentic glomerulonephritis and Churg-Strauss syndrome. They are detected as perinuclear ANCAs (pANCAs), as opposed to the cytoplasmic ANCAs (cANCAs) against proteinase 3 (PR3), which are strongly associated with Wegener's granulomatosis.
Diagnostic use
Routine testing of MPO is not performed. A 2003 study suggested that it could serve as a sensitive predictor for myocardial infarction in patients presenting with chest pain.[1] Currently, PrognostiX Inc., run out of the Cleveland Clinic in Cleveland, Ohio, is the only company to have an FDA approved ELISA test kit for MPO concentration. The product is known as CardioMPO and is used in clinical settings to triage patients that present chest pain. It operates using the sandwich ELISA method.
Historically, immunohistochemical staining for myeloperoxidase was used in the diagnosis of acute myeloid leukemia to demonstrate that the leukemic cells were derived from the myeloid lineage. However, more recently, the use of myeloperoxidase staining in this setting has been supplanted by the widespread use of flow cytometry. Myeloperoxidase staining is still important in the diagnosis of extramedullary leukemia, or chloroma.
See also
References
Oxidoreductases: peroxidases (EC 1.11) |
|---|
| Catalase - Cytochrome c peroxidase - Eosinophil peroxidase - Glutathione peroxidase - Horseradish peroxidase - Lactoperoxidase - Myeloperoxidase - Thyroid peroxidase - Deiodinase (Tetraiodothyronine 5' deiodinase) |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
